Keep up with Amgen and more.
Amgen is a global biotechnology leader focused on developing and delivering breakthrough therapies for serious diseases. The company leverages cutting-edge science to address critical health challenges, with a portfolio that includes treatments for cancer, cardiovascular conditions, and other major illnesses. Operating in nearly 100 countries, Amgen is dedicated to transforming the potential of biotechnology into real-world solutions that improve patient lives and advance healthcare worldwide.
Discover the world's most disruptive early stage companies with 35,000+ investors.
The markets and trends that matter, made simple.
Join top talent at the world's most respected institutions, companies, and venture capital funds.